Cardiomyopathy Clinical Trials

Find Cardiomyopathy Clinical Trials Near You

AtrioVentricular Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function - a Randomized Controlled Trial

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

AVA CONDUCT is a prospective, multicenter, randomized study with single blinding, comparing left bundle branch area (LBBA) pacing with right ventricular (RV) pacing following AV node ablation in terms of clinical, functional, and electrophysiological outcomes. The primary hypothesis is that pacing-induced cardiomyopathy, defined as a decrease in LVEF by 10% or more from baseline to an absolute value below 50%, occurs significantly more frequently in patients receiving RV pacing compared with LBBA pacing. Secondarily, LBBA pacing is expected to maintain comparable procedural safety while providing better cardiac function, resulting in improved quality of life and functional capacity compared with conventional RV pacing.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• History of symptomatic AF (EHRA IIb - IV) despite guideline-indicated medical or interventional therapy

• Preserved LVEF (≥ 50%, assessed by echocardiography, Simpson's biplane method)

• AV node ablation scheduled independently of possible study participation

• Age ≥ 18 years

• Consent capacity

Locations
Other Locations
Germany
Evangelisches Krankenhaus Hagen-Haspe
NOT_YET_RECRUITING
Hagen
St. Josefs-Hospital Wiesbaden GmbH
RECRUITING
Wiesbaden
Time Frame
Start Date: 2026-02-01
Estimated Completion Date: 2029-12-31
Participants
Target number of participants: 86
Treatments
Active_comparator: Right ventricular pacing
Active_comparator: Left bundle branch area pacing
Related Therapeutic Areas
Sponsors
Leads: St. Josefs-Hospital Wiesbaden GmbH

This content was sourced from clinicaltrials.gov